Webinars and eLearning

A live Question & Answer session for attendees interested in beginning their own program will also be offered.

This 20-minute, self-paced eCourse offers financial navigators foundational knowledge of biomarkers testing, and insurance guidelines. Learners will gain access to financial and educational resources, practice clear communication strategies to improve patient comprehension and explore best practices for prior authorization.

Now available is a 30-minute eCourse for members of the multidisciplinary cancer care team on how to use consistent, evidence-based health literacy best practices as it relates to lung cancer biomarker testing. Complete “Health Literacy Best Practices for Lung Cancer Biomarkers” to gain a lexicon of health terminology that resonates with patients and their caregivers and access downloadable resources about health literacy and biomarkers.

Explore the impact of ACCC’s quality improvement initiative on several ovarian cancer care programs and learn about the ovarian quality of care self-assessment tool.

Review key issues and takeaways during early phases of this ovarian cancer care quality improvement initiative.

In this final webinar, hear from our experts Jordan Karwedsky, Financial Counselor, Green Bay Oncology, Wendi Waugh, BS, RT(R)(T), CMD, CRT, Administrative Director of SOMC Cancer Services & Ambulatory Infusion, Southern Ohio Medical Center, and Dr. Michael R. Gieske, Director of Lung Cancer Screening. Join us as we discuss prior authorization challenges in biomarker testing, importance of providing access to biomarker testing for underserved populations, how biomarkers are shaping the future of medicine, as well as what can be done at the policy level to allow for more access.

The unwinding of Medicaid has begun and affects one of the most vulnerable U.S. regions’ access to cancer-related services—from screening to treatment. In this webinar, the Appalachian Community Cancer Alliance provides an opportunity to gain insight on the scale of impact and how to help ensure continued access to cancer screening and treatment services for this patient population.